Chapters

Transcript

Video

Trial 20-153: SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer

Why test the combination of Trodelvy and pembrolizumab? Previous efforts testing immunotherapy for HR+ breast cancer has shown disappointing results.


Published

March 26, 2021

Created by

Dana-Farber

Related Presenters

Filipa Lynce, MD

Filipa Lynce, MD

Medical Oncology

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004.

View Profile